Investigating how xylazine affects behaviors caused by methamphetamine

Xylazine effects on methamphetamine-induced behavioral alterations in rats

NIH-funded research Temple Univ of the Commonwealth · NIH-11145507

This study is looking at how xylazine, which is sometimes mixed with methamphetamine, affects the behavior of rats to help us understand how these substances might make each other worse, and the results could help improve public health efforts related to drug use.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-11145507 on NIH RePORTER

What this research studies

This research explores the effects of xylazine, a substance increasingly found in methamphetamine, on behavioral changes in rats. By conducting preclinical studies, the researchers aim to understand how xylazine interacts with methamphetamine and potentially worsens its effects. The study will evaluate various behavioral responses, including locomotor activity and self-administration behaviors, to provide insights into the implications of co-exposure to these substances. The findings could inform public health strategies regarding methamphetamine and xylazine misuse.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research would be individuals struggling with methamphetamine addiction, particularly those who may also be exposed to xylazine.

Not a fit: Patients who are not involved with methamphetamine or xylazine use may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for individuals affected by methamphetamine and xylazine co-use.

How similar studies have performed: While there has been limited research on the specific interactions between xylazine and methamphetamine, previous studies have shown some success in understanding the effects of xylazine on other substances.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.